Matches 1 - 12 out of 12


Match Document Document Title
DE102017002810A1 Sialic acid derivatives with CC triple bond and their preparation  
Sialic acid derivatives containing a CC triple bond are described, processes for their preparation, conjugates prepared therefrom, and pharmaceutical compositions containing them.
DE102008024309A1 New tetrahydro-pyran compounds useful to prepare 2-desoxy-2-(F-18)fluoroglucosyl-1-azide, which is useful for F-18-glycosylation of bioactive alkynyl or ethinyl derivatized molecule to form conjugated tetrahydro-pyran biomolecule  
Tetrahydro-pyran compounds (I) are new. Tetrahydro-pyran compounds of formula (I) are new. 3 of R 1-R 4= a leaving group comprising OAc and the other is OSO 2R', and R'= methyl, trifluoromethyl or...
DE102006053637B4 Last fluoro-substituted 1,4-Benzothiepin-1,1-dioxide derivatives, pharmaceutical compositions containing them and their use  
Compounds of the formula I, which mean X NH; R1 (C1-C6) Alkyl; R4 F; R4 'H, F; R2, R2 ', R3, R3', R5, R5 'independently of one another H, F, Cl, Br, I, OH, - (CH2) -OH, CH2F, CHF2, CF3, NO2, N3,...
DE102006053637A1 New fluorine-substituted 1,4-benzothiepine-1,1-dioxide, a process for their production, medicaments containing these compounds and their use  
The Invention relates to the compounds of formula I and physiologically acceptable Salts. The compounds are suitable for. B. as hypolipidemic agents.
DE102006053635A1 New substituted with benzyl 1,4-Benzothiepin-1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use  
The Invention relates to the compounds of formula I and physiologically acceptable Salts. The connection is suitable for. B. as hypolipidemic agents.
DE102006053635B4 New substituted with benzyl 1,4-Benzothiepin-1,1-dioxide derivatives, pharmaceutical compositions containing them and their use  
Compounds of formula and the pharmaceutically acceptable salts thereof.
DE102005033099A1 New 1,4-benzothiazepine-1,1-Dioxidderivat with improved properties, process for its preparation, pharmaceuticals comprising this compound and its use  
The Invention relates to the compound of formula A and physiologically acceptable Salts. The connection is suitable for. B. as Hypolipidämikum.
DE19911504B4 A process for the industrial oxidation of alcohols, aldehydes or polyhydroxy compounds  
process for the industrial oxidation of alcohols, aldehydes or polyhydroxy compounds in aqueous Phase, characterized in that the oxidation catalytic using a noble metal catalyst, the precious...
DE19911504A1 A process for the industrial oxidation of alcohols, aldehydes or polyhydroxy compounds  
For the industrial oxidation of alcohols, aldehydes or polyhydroxy compounds in the aqueous phase, the oxidation is carried out catalytically using a noble metal catalyst formed from...
DE19503423A1 Anti-adhesive agents  
The invention concerns the use of a compound or a number of compounds from the group of the carbohydrates or carbohydrate derivatives as anti-adhesive active principles directed against...
DE3829552A1 MILK INGREDIENTS, METHOD FOR THE PRODUCTION AND MEANS THAT THESE COMPONENTS CONTAIN  
Constituents of the non-protein-nitrogen fraction of untreated raw milk or fresh milk have a characteristic pharmacological activity.
DE3531102A1 Epiminopyranosides, process for their preparation, and their use  
3,4-Dideoxy-3,4-epiminopyranosides are described, in which the free hydroxy group is in the 2-position in the trans-position to the epimino group, and 2,3-dideoxy-2,3-epiminopyranosides in which...

Matches 1 - 12 out of 12